It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Lipid droplets (LDs) feature a unique monolayer lipid membrane that has not been extensively studied due to the lack of suitable molecular probes that are able to distinguish this membrane from the LD lipid core. In this work, we present a three-pronged molecular probe design strategy that combines lipophilicity-based organelle targeting with microenvironment-dependent activation and design an LD membrane labeling pro-probe called LDM. Upon activation by the HClO/ClO− microenvironment that surrounds LDs, LDM pro-probe releases LDM-OH probe that binds to LD membrane proteins thus enabling visualization of the ring-like LD membrane. By utilizing LDM, we identify the dynamic mechanism of LD membrane contacts and their protein accumulation parameters. Taken together, LDM represents the first molecular probe for imaging LD membranes in live cells to the best of our knowledge, and represents an attractive tool for further investigations into the specific regulatory mechanisms with LD-related metabolism diseases and drug screening.
Lipid droplets (LDs) and their membrane proteins play essential roles in many biological processes, but the monolayer lipid membrane of LDs has not been extensively studied due to the lack of suitable molecular probes. Here, the authors report an LD membrane labelling pro-probe called LDM, which, upon activation by the HClO/ClO− microenvironment that surrounds LDs, undergoes a color change and releases LDM-OH probe that binds to LD membrane proteins.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Shandong First Medical University & Shandong Academy of Medical Sciences, School of Pharmaceutical Sciences, Jinan, PR China (GRID:grid.410587.f)
2 Shandong First Medical University & Shandong Academy of Medical Sciences, School of Pharmaceutical Sciences, Jinan, PR China (GRID:grid.410587.f); Shandong First Medical University & Shandong Academy of Medical Sciences, Medical Science and Technology Innovation Center, Jinan, PR China (GRID:grid.410587.f)
3 National University of Singapore, Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Helios, Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, 11 Biopolis Way, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
4 Shandong First Medical University & Shandong Academy of Medical Sciences, School of Pharmaceutical Sciences, Jinan, PR China (GRID:grid.410587.f); Jinan University, College of Pharmacy, Guangzhou, PR China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548)
5 Shandong First Medical University & Shandong Academy of Medical Sciences, School of Pharmaceutical Sciences, Jinan, PR China (GRID:grid.410587.f); Shandong First Medical University & Shandong Academy of Medical Sciences, Medical Science and Technology Innovation Center, Jinan, PR China (GRID:grid.410587.f); Shandong First Medical University & Shandong Academy of Medical Sciences, Neck-Shoulder and Lumbocrural Pain Hospital, Jinan, PR China (GRID:grid.410587.f)
6 Shandong First Medical University & Shandong Academy of Medical Sciences, Medical Science and Technology Innovation Center, Jinan, PR China (GRID:grid.410587.f)
7 Shandong First Medical University & Shandong Academy of Medical Sciences, Medical Science and Technology Innovation Center, Jinan, PR China (GRID:grid.410587.f); Shandong First Medical University & Shandong Academy of Medical Sciences, Neck-Shoulder and Lumbocrural Pain Hospital, Jinan, PR China (GRID:grid.410587.f)
8 Nanjing Normal University, College of Chemistry and Materials Science, Nanjing, PR China (GRID:grid.260474.3) (ISNI:0000 0001 0089 5711)
9 National University of Singapore, Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Helios, Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, 11 Biopolis Way, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Proteos, Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), 61 Biopolis Drive, Singapore, Singapore (GRID:grid.418812.6) (ISNI:0000 0004 0620 9243)
10 Shandong First Medical University & Shandong Academy of Medical Sciences, School of Pharmaceutical Sciences, Jinan, PR China (GRID:grid.410587.f); Shandong First Medical University & Shandong Academy of Medical Sciences, Medical Science and Technology Innovation Center, Jinan, PR China (GRID:grid.410587.f); National University of Singapore, Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); National University of Singapore, Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Helios, Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, 11 Biopolis Way, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Proteos, Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), 61 Biopolis Drive, Singapore, Singapore (GRID:grid.418812.6) (ISNI:0000 0004 0620 9243)